Allogene Therapeutics, Inc. (ALLO) Tops Q3 EPS by 3c

Allogene Therapeutics, Inc. (NASDAQ: ALLO) reported Q3 EPS of ($0.19), $0.03 better than the analyst estimate of ($0.22).

For earnings history and earnings-related data on Allogene Therapeutics, Inc. (ALLO) click here.

You May Also Be Interested In

• Tesla readies August launch of CyberCab - The Information
• Market Vectors Semiconductor ETF (SMH) call put ratio 1 call to 1.7 puts as share price up 1%
• BofA sees Micron EPS topping $230 by FY30, calls peak fears overblown